SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-030949
Filing Date
2021-03-02
Accepted
2021-03-02 19:42:02
Documents
1
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm218516-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm218516-4_4seq1.xml 4 3360
  Complete submission text file 0001104659-21-030949.txt   4825
Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Schroeder Theodore R (Reporting) CIK: 0001378690 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37558 | Film No.: 21706274

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Issuer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations